Medtronic (MDT) Receives FDA Approval of Claria MRI CRT-D SureScan Device

November 14, 2016 9:17 AM EST Send to a Friend
Medtronic (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for the Claria MRI Quad Cardiac Resynchronization Therapy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login